NCT06400251

Clinical Trial Information


Trial Number: NCT06400251 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Hematopoietic Neoplasm/Myeloma - Myeloma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol Z1K: Ipatasertib in Patients With Tumors With AKT Mutations"
Study ID:
EAY131-Z1K
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®